Glenmark Pharmaceuticals Inc., USA (Glenmark) has received final approval by the United States Food & Drug Administration (U.S. FDA) for Olopatadine Hydrochloride Ophthalmic Solution USP, 0.2% (OTC), ...

The inspection comes after a ProPublica investigation revealed that drugs made at the Glenmark Pharmaceuticals plant ...

Eli Lilly (LLY) has launched its weight-loss and diabetes drug, Mounjaro (tirzepatide), in India, securing a first-mover ...

Glenmark Therapeutics Inc., USA (Glenmark) is pleased to announce the launch1 of Polyethylene Glycol 3350, Powder for ...

Glenmark Pharmaceuticals Ltd is quoting at Rs 1380.8, up 3.49% on the day as on 12:49 IST on the NSE. The stock is up 49.05% in last one year as compared to a 0.46% fall in NIFTY and a 4.57% fall in ...

New Delhi: Cancer patients facing prohibitive treatment costs in India can hope for relief: the nation's top drugmakers have started manufacturing key medicines for such diseases in the country.

Glenmark Pharma, an India-based drug manufacturer that has been the focal point of a spate of recalls in recent years, has issued another. This time, the product pull covers about 1.48 million ...

Glenmark Pharmaceuticals Inc., USA (Glenmark) announces the acquisition and launch of acetylcysteine injection, 6 gm/30 mL (200 mg/mL) single-dose vials. Glenmark’s acetylcysteine injection, 6 gm/30 ...

Glenmark Pharmaceuticals Ltd. (BSE: 532296) (NSE: GLENMARK) is a research–led, global pharmaceutical company, having a presence across Branded, Generics, and OTC segments; with a focus on ...

Pharma major Glenmark Pharmaceuticals is recalling close to 15 lakh bottles of a generic medication used in the treatment of attention deficit hyperactivity disorder in the US market. According to ...

Glenmark Pharmaceuticals on Thursday said its US-based subsidiary has launched of epinephrine injection USP, used to treat severe allergic reactions. The injection has been launched in the strength of ...